FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Gilead Sciences
(NQ:
GILD
)
144.63
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gilead Sciences
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
78
79
Next >
Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
↗
July 08, 2024
Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health.
Via
Talk Markets
This Domino's Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
↗
July 08, 2024
Via
Benzinga
Amgen, Inc. Dividend Stock Analysis
↗
July 05, 2024
Amgen Inc. is one of the world's leading biotech companies with major treatments for anemia, neutropenia, rheumatoid and psoriatic arthritis, psoriasis, cancer and osteoporosis.
Via
Talk Markets
FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals
↗
July 04, 2024
Biotech stocks are on the verge of a comeback after a period of underperformance amid a wave of FDA approvals.
Via
InvestorPlace
3 Undervalued Biotech Gems With 200%+ Analyst Price Targets
↗
July 04, 2024
These three undervalued biotech stocks have begun garnering investor attention as their treatments show promise.
Via
InvestorPlace
Key Takeaways From Gilead Sciences Analyst Ratings
↗
July 01, 2024
Via
Benzinga
Gilead Sciences's Options Frenzy: What You Need to Know
↗
June 24, 2024
Via
Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $800 Today
↗
June 19, 2024
Via
Benzinga
3 Magnificent Stocks Retirees Can Buy and Hold Forever
↗
July 01, 2024
These stocks could be ideal for investors in their golden years.
Via
The Motley Fool
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
↗
June 28, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
June 25, 2024
Via
Benzinga
7 Dividend Stocks to Buy Now: June 2024
↗
June 23, 2024
These dividend stocks to buy now will reward investors with income now and growth as the market breadth expands.
Via
InvestorPlace
DraftKings And Dell Were Among The 10 Biggest Large Cap Stock Gainers Last Week (June 16-June 22): Are These In Your Portfolio?
↗
June 23, 2024
Top performers last week were SRPT (+29.50%), SIRI (+16.73%), TOST (+15.57%), GILD (+12.62%), CHWY (+10.59%), ACN (+9.80%), DKNG (+9.69%), DELL (+8.19%), ADSK (+7.99%), and GFI (+7.15%).
Via
Benzinga
MarketBeat Week in Review – 6/17 - 6/21
June 22, 2024
Markets were calmer this week, with the Dow index posting the biggest gains, but it's too early to tell if this is the start of a broader market rally
Via
MarketBeat
Topics
Economy
Stocks
Top Analyst Reports For Abbott, BP & Gilead
↗
June 21, 2024
Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories, BP p.l.c.and Gilead Sciences, Inc., as well as two micro-cap stocks Smith-Midland Corp. and...
Via
Talk Markets
Nvidia Snaps 8-Week Winning Run, S&P 500 Marks Longest Streak Without A 2% Drop Since Great Recession, Oil Prices Stage Comeback: This Week In The Market
↗
June 21, 2024
Stock market rally continues with new highs in S&P 500 and Nasdaq 100, driven by tech and semiconductor sectors, but concerns arise over lack of broad participation and high concentration in mega-cap...
Via
Benzinga
Topics
Economy
Stocks
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
↗
June 21, 2024
Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatments.
Via
Benzinga
Why Gilead Sciences Stock Is Trading Higher Friday
↗
June 21, 2024
On Thursday before the market opened, Gilead announced efficacy data for its possible HIV prevention drug, Lenacapavir.
Via
Benzinga
Pre-Market Movers - June 21, 2024
↗
June 21, 2024
Sarepta jumps after announcing expanded approval of DMD drug and more news on today's top movers.
Via
Talk Markets
Gilead Sciences Stock Surges on HIV Treatment Trial Success
June 21, 2024
Gilead Sciences (NASDAQ: GILD) saw its stock jump nearly 10% yesterday after announcing groundbreaking results from its HIV treatment trial.
Via
MarketBeat
Defying the Norms: 3 High P/E Stocks With Room to Run
↗
June 21, 2024
Gilead Sciences, Crowdstrike and DataDog might be the best high P/E stocks to buy, offering substantial growth despite elevated valuations.
Via
InvestorPlace
S&P 500, Nasdaq 100 Dip From Record Highs As Investors Take Chipmaker Profits; Energy Sector Rebounds, Yields Rise: What's Driving Markets Thursday?
↗
June 20, 2024
After the Juneteenth holiday break, Wall Street reopened with a cautious tone, as the S&P 500 and Nasdaq 100 indices declined after hitting all-time highs around midday trading in New York. This...
Via
Benzinga
Topics
Stocks
Gilead Flashes A Bullish Sign After HIV Drug Proves 100% Effective
↗
June 20, 2024
The company tested its HIV prevention drug in cisgender women in Uganda and South Africa.
Via
Investor's Business Daily
Why Is Gilead Sciences Stock Trading Higher On Thursday?
↗
June 20, 2024
Gilead Sciences announced its Phase 3 PURPOSE 1 trial results showing 100% efficacy of twice-yearly injectable lenacapavir in preventing HIV-1 in cisgender women. The trial met key efficacy endpoints,...
Via
Benzinga
KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday
↗
June 20, 2024
Via
Benzinga
Gilead’s Twice-Yearly Lenacapavir Demonstrated 100% Efficacy and Superiority to Daily Truvada® for HIV Prevention
June 20, 2024
From
Gilead Sciences, Inc.
Via
Business Wire
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033
June 20, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:KYMR),(NASDAQ:GILD),(OTCQX:RHHBY),(NASDAQ:AMGN) EQNX::TICKER_END
Via
FinancialNewsMedia
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
↗
June 17, 2024
With biotech stocks enjoying a permanently relevant narrative, investors should focus on these compelling opportunities.
Via
InvestorPlace
Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender
↗
June 17, 2024
The company tested a GLP-1 drug in monkeys. But it might not actually be an obesity treatment.
Via
Investor's Business Daily
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033
June 20, 2024
From
FN Media Group LLC
Via
GlobeNewswire
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
78
79
Next >
